3 ms·
It's possible 23andme has been sloppy with its compliance practices. If you take the raw data and download various utilities that match SNPs with the literatur
by grandalf 13y ago
It's possible 23andme has been sloppy with its compliance practices.
If you take the raw data and download various utilities that match SNPs with the literature, the result is far more scary and misleading -- and it reveals just how thoughtful and reserved 23andme's approach is.
23andme provides ample links to evidence for every single result. The confidence metric is a function of the study size and reproducibility for the studies pertaining to each and every result. Most have very low confidence.
IMHO the only legitimate beef is with the underlying scientific assumption behind 23andme, which is that statistical genetics is both useful and accurate. I consider it more of a form of entertainment than a likely way of gathering actionable information.
- dragonwriter 13y ago> It's possible 23andme has been sloppy with its compliance practices. Then no one should be surprised that they are in trouble with a regulatory agency responsible for holding participants in the market they are in to compliance standards.
- grandalf 13y agoActually I think it's quite surprising. Why would a well-funded company pursuing a business model that clearly falls into a regulatory gray area gamble with its future by simply not complying?
- dragonwriter 13y agoSeems to be not-too-rare practice with startups -- don't comply and hope the rules adapt to them rather than vice versa (either by legislation or litigation.) AirBnB, Uber/Lyft, 23andMe previously (with then-current California regulation requiring tests of the type they provide to be physician-ordered) have all done this with varying degrees of success.